|
|
|
|
Founder of Baker Bros. Advisors LP, Felix James Baker currently is Managing Partner at this company and Co-Managing Partner at Baker Bros. Advisors GP LLC (a subsidiary of Baker Bros. Advisors LP).
He is also on the board of Alexion Pharmaceuticals, Inc., Seattle Genetics, Inc., Kiniksa Pharmaceuticals Ltd. and Kodiak Sciences, Inc. and Manager at Fbb2 LLC, Co-Managing Partner at Baker Bros. Advisors GP LLC and Partner at FBB Associates.
In the past he was Chairman for Synageva BioPharma Corp. and Owner at VaxGen, Inc.
Dr. Baker received a doctorate and an undergraduate degree from Stanford University.
|
| Postes et responsabilités de Felix James Baker | |
|
| Nom | Titre |
Depuis |
 Alexion Pharmaceuticals, Inc.
(Produits pharmaceutiques) |
Independent Director |
2015 | Seagen Inc.
(Recherche biotechnologique et médicale) |
Lead Independent Director |
2005 | Kodiak Sciences Inc.
(Recherche biotechnologique et médicale) |
Independent Director |
2015 | Kiniksa Pharmaceuticals, Ltd.
(Recherche biotechnologique et médicale) |
Lead Independent Director |
2015 | | Fbb2 LLC |
Manager |
- | | Baker Bros. Advisors GP LLC |
Co-Managing Partner |
- | | FBB Associates |
Partner |
- | | Baker Bros. Advisors LP |
Managing Partner |
2000 |
|
| Participations de Felix James Baker | |
|
| Nom | Actions | % | Valorisation |
Seagen Inc. (SGEN)
(Recherche biotechnologique et médicale) | 181 740 | 0,10% | 31 829 944 USD |
Incyte Corporation (INCY)
(Recherche biotechnologique et médicale) | 281 190 | 0,13% | 24 457 906 USD |
Alexion Pharmaceuticals, Inc. (ALXN)
(Produits pharmaceutiques) | 65 810 | 0,030% | 10 282 154 USD |
 BeiGene, Ltd. (6160)
(Recherche biotechnologique et médicale) | 311 143 | 0,026% | 6 300 027 USD |
ACADIA Pharmaceuticals Inc. (ACAD)
(Recherche biotechnologique et médicale) | 102 876 | 0,065% | 5 499 751 USD |
Idera Pharmaceuticals, Inc. (IDRA)
(Recherche biotechnologique et médicale) | 21 929 | 0,062% | 80 479 USD |
Neoleukin Therapeutics, Inc. (NLTX)
(Recherche biotechnologique et médicale) | 2 260 | 0,0054% | 31 866 USD |
Mirati Therapeutics, Inc. (MRTX)
(Recherche biotechnologique et médicale) | 137 | 0,0003% | 30 091 USD |
|
| Felix James Baker: Réseau personnel | |
|
|
© 2021 People and Ownership : 
|
|
|
| Felix James Baker : Connexions | |
|
|
|
Canada
Deutschland
España
Italia
Schweiz (DE)
United Kingdom
United States
bourse
